PBI-6DNJ is an orally active and potent multivalent glycosidase inhibitor. PBI-6DNJ exhibits good inhibition activity against alpha-glucosidase from mice, with a Ki of 0.14 µM. PBI-6DNJ exhibits good hypoglycemic activity. PBI-6DNJ can be used for type 2 diabetes research[1].
Molecular Weight:
2528.60
CAS Number:
[2857098-72-5]
Formula:
C120H146N26O36
Target:
Glycosidase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted